New challenge to cancer and longevity

Medical Corporation “Saisei Mirai”, Osaka, Japan

“Saisei Mirai” has been focusing on cancer treatments and has developed several new treatments, including GcMAF ( Gc protein-derived Macrophage Activating Factor ) and oral MAF ( Macrophage Activating Factor) which are immunotherapies developed by “Saisei Mirai”. We are collaborating with 6 universities here in Japan to develop new and better treatments mainly for cancer. At the same time, GcMAF and oral MAF showed good effects for many infectious agents, autism spectrum disorder (ASD), chronic fatigue syndrome (CFS), atopic dermatitis, hair loss, multiple sclerosis, autoimmune diseases, injuries and so on. First, I'll explain our cancer treatments. A. Local destruction of cancer tissue

• 1.    Sonodynamic therapy

• 2.    HIFU (High Intensity Focused Ultrasound)

• 3.    Tumor Treating Fields therapy

• B.    Immunotherapy

• 1.    GcMAF injection

• 2.    Oral MAF produced from bovine milk

• 3.    Hyper T/NK cell therapy

• 4.    Autologous cancer vaccine

• 5.    Coley vaccine (Fever therapy)

• 6.    Dendritic cell therapy

• C.    Other treatments

• 1.    New liposomal P53 and PTEN gene therapy

• 2.    High dose vitamin C therapy

• 3.    Ozone therapy

• 4.    Hypoxia therapy

• 5.    Hyperbaric oxygen chamber

Originally our aim was to destroy local cancer tissue in combination with various immunotherapies, which is a very good combination in my opinion. Recently something very new and very interesting was added to our aim.

Usually, we use GcMAF injection and oral MAF for many patients and what happened to them was amazing and beyond my understanding in the beginning. During the cancer treatments and antiaging treatments, we have observed some very good changes in many patients, which was not only that they had increased energy, but they also had silky and beautiful skin and increased hair volume with new black hair from gray hair, and they were looking younger and healthier. Although these cosmetic changes didn't happen to terminal cancer patients, they but happened to many other patients.

Given these clinical observations, I considered many times why rejuvenation and regeneration had occurred in so many patients in such a short time and then suddenly I saw a light. This must be associated with telomere length, because it's now emerging that telomere shortening is associated with age-related degenerative disease, increased risk of cancer and life shortening. That's why I decided to start a clinical trial in Japan using MAF capsules for longevity by measuring telomere length.

I'm going to tell you in detail about our preliminary clinical trial results using MAF Triple for longevity in the latter part of my speech. They are simply amazing as we succeeded in extending telomere length and I believe that extended telomere length will contribute to reducing the risk of getting age-related degenerative disease as well as the risk of developing cancer.

At the end, I'd like to add one thing that the name MAF (Macrophage Activating Factor) is good but it's not enough to explain all of the MAF capsule's abilities and functions. Given the fact that MAF capsules can extend telomere length, the name MAF can be changed to TEF (Telomere Extending Factor) in a broad sense.